Primary Bedaquiline Resistance Among Cases of Drug-Resistant Tuberculosis in Taiwan

Bedaquiline (BDQ), which is recommended for the treatment of drug-resistant tuberculosis (DR-TB), was introduced in Taiwan in 2014. Due to the alarming emergence of BDQ resistance, we conducted BDQ resistance analyses to strengthen our DR-TB management program. This retrospective population-based st...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Sheng-Han, Chan, Hsin-Hua, Hsiao, Hseuh-Chien, Jou, Ruwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569445/
https://www.ncbi.nlm.nih.gov/pubmed/34745058
http://dx.doi.org/10.3389/fmicb.2021.754249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569445/
https://www.ncbi.nlm.nih.gov/pubmed/34745058
http://dx.doi.org/10.3389/fmicb.2021.754249

Ejemplares similares